Royal Bank of Canada
WVE icon

Royal Bank of Canada’s Wave Life Sciences WVE Stock Holding History

Royal Bank of Canada’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$122K Sell
16,702
-6,504
-28% -$84.7K ﹤0.01% 5013
2025
Q4 		$396K Sell
23,206
-147,292
-86% -$1.5M ﹤0.01% 4345
2025
Q3 		$1.25M Buy
170,498
+143,663
+535% +$1.16M ﹤0.01% 3794
2025
Q2 		$175K Buy
26,835
+25,709
+2,283% +$170K ﹤0.01% 5261
2025
Q1 		$9K Sell
1,126
-3,563
-76% -$39K ﹤0.01% 6202
2024
Q4 		$58K Sell
4,689
-3,791
-45% -$50.6K ﹤0.01% 5617
2024
Q3 		$70K Buy
8,480
+698
+9% +$4.17K ﹤0.01% 5545
2024
Q2 		$38K Buy
7,782
+4,265
+121% +$24.3K ﹤0.01% 5783
2024
Q1 		$22K Sell
3,517
-15,314
-81% -$76.7K ﹤0.01% 5890
2023
Q4 		$95K Buy
18,831
+8,404
+81% +$44.9K ﹤0.01% 5656
2023
Q3 		$60K Buy
10,427
+1,640
+19% +$7.49K ﹤0.01% 5689
2023
Q2 		$32K Buy
8,787
+6,332
+258% +$25.6K ﹤0.01% 5983
2023
Q1 		$11K Buy
2,455
+423
+21% +$1.94K ﹤0.01% 6286
2022
Q4 		$14K Sell
2,032
-777
-28% -$3.58K ﹤0.01% 6433
2022
Q3 		$10K Buy
2,809
+2,218
+375% +$7.34K ﹤0.01% 6437
2022
Q2 		$2K Sell
591
-2,629
-82% -$5.06K ﹤0.01% 7009
2022
Q1 		$6K Sell
3,220
-7,700
-71% -$18.9K ﹤0.01% 7204
2021
Q4 		$34K Buy
10,920
+7,222
+195% +$30K ﹤0.01% 6577
2021
Q3 		$18K Buy
3,698
+630
+21% +$3.82K ﹤0.01% 6749
2021
Q2 		$20K Buy
3,068
+46
+2% +$301 ﹤0.01% 6572
2021
Q1 		$17K Buy
3,022
+2,522
+504% +$24.2K ﹤0.01% 6533
2020
Q4 		$4K Hold
500
– – ﹤0.01% 6752
2020
Q3 		$4K Sell
500
-46
-8% -$504 ﹤0.01% 6194
2020
Q2 		$6K Sell
546
-52
-9% -$489 ﹤0.01% 6004
2020
Q1 		$6K Sell
598
-1,324
-69% -$11.3K ﹤0.01% 5997
2019
Q4 		$16K Buy
1,922
+1,422
+284% +$34.9K ﹤0.01% 5966
2019
Q3 		$10K Hold
500
– – ﹤0.01% 5789
2019
Q2 		$13K Hold
500
– – ﹤0.01% 5940
2019
Q1 		$19K Hold
500
– – ﹤0.01% 5683
2018
Q4 		$21K Sell
500
-155
-24% -$6.89K ﹤0.01% 5575
2018
Q3 		$32K Buy
655
+155
+31% +$6.99K ﹤0.01% 5451
2018
Q2 		$19K Sell
500
-150
-23% -$6.46K ﹤0.01% 5567
2018
Q1 		$26K Buy
650
+150
+30% +$6.31K ﹤0.01% 5353
2017
Q4 		$18K Sell
500
-943
-65% -$27.5K ﹤0.01% 5637
2017
Q3 		$32K Buy
1,443
+911
+171% +$18.3K ﹤0.01% 5688
2017
Q2 		$9K Sell
532
-108
-17% -$2.33K ﹤0.01% 5855
2017
Q1 		$18K Sell
640
-128
-17% -$3.58K ﹤0.01% 5683
2016
Q4 		$20K Buy
768
+468
+156% +$15.2K ﹤0.01% 5772
2016
Q3 		$10K Hold
300
– – ﹤0.01% 5792
2016
Q2 		$6K Hold
300
– – ﹤0.01% 5902
2016
Q1 		$4K Hold
300
– – ﹤0.01% 5986
2015
Q4 		$5K Buy
+300
New +$4.7K ﹤0.01% 6168

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Royal Bank of Canada's WVE Position: Q1 2026 in Review

Royal Bank of Canada reduced its Wave Life Sciences (WVE) stake by 28% in Q1 2026, selling an estimated $84.7K and leaving 16,702 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #5013.

Royal Bank of Canada first reported a position in WVE in Q4 2015 and has held it in 42 quarters since. The position peaked at $1.25M in Q3 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Royal Bank of Canada held 16,702 shares of Wave Life Sciences worth $122K as of Q1 2026.
  • Royal Bank of Canada sold 6,504 Wave Life Sciences shares in Q1 2026, an estimated $84.7K.
  • Wave Life Sciences made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5013 holding.
  • Royal Bank of Canada first reported a position in Wave Life Sciences in Q4 2015 and has held it in 42 quarters since.
  • Royal Bank of Canada's Wave Life Sciences position peaked at $1.25M in Q3 2025.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.